21 min listen
News from EAU20, ISTH, and AACR's COVID-19 & Cancer meeting: Surgery in renal cell cancer, bevacizumab in HHT, and nosocomial COVID-19
FromBlood & Cancer
News from EAU20, ISTH, and AACR's COVID-19 & Cancer meeting: Surgery in renal cell cancer, bevacizumab in HHT, and nosocomial COVID-19
FromBlood & Cancer
ratings:
Length:
11 minutes
Released:
Aug 4, 2020
Format:
Podcast episode
Description
Subscribe to Blood & Cancer: Apple Podcasts, Spotify, Google Podcasts This week in HemOnc News: Higher death rate seen in cancer patients with nosocomial COVID-19 Article: https://bit.ly/2XjRLDq Source: https://bit.ly/3goLGgF Robotic renal surgery bests open partial nephrectomy Article: https://bit.ly/2PhHS4MSource: https://bit.ly/3gqXXBd Large cohort study: Bevacizumab safe, effective for severe HHT bleeds Article: https://bit.ly/2XpuZdjSource: https://bit.ly/2BXHVQg For more MDedge Podcasts, click this link: http://bit.ly/2CfnY52 Email the show: podcasts@mdedge.com Follow Dr. David Henry on Twitter @DavidHenryMD
Released:
Aug 4, 2020
Format:
Podcast episode
Titles in the series (100)
2019 drug approvals in hematology-oncology: , of the University of Pennsylvania, Philadelphia, joins the podcast to discuss noteworthy drug approvals in hematology-oncology in 2019. Dr. Mintzer and Blood & Cancer host, , of Pennsylvania Hospital, Philadelphia, discuss what these new... by Blood & Cancer